Scientists uncover how a genetic mutation linked to Huntington's disease stays harmless for years before expanding and causing cell death. The study discovers that DNA repeats must exceed 150 CAGs to ...
The Food and Drug Administration (FDA) has approved Calquence ® (acalabrutinib) in combination with bendamustine and rituximab for the treatment of adults with previously untreated mantle cell ...
Some results have been hidden because they may be inaccessible to you